According to TPP's leaked text on Intellectual Property, the U.S. is pushing for agressive measures that would further endanger access to affordable medicines against cancer, heart disease and HIV/AIDS, among others.

The U.S has proposed TRIPS+ and FTA+ terms that would transform Vietnam's Laws on patents and clinical trial test data and attack government purchasing and medicine formunlaries. These provisions would limit generic competition and raise pharmaceutical prices, thereby restricting access to affordable medicines. The same provisions would hinder local pharmaceutical production and innovation in Vietnam.

See the full analysis here:

• Exporting to the Canadian market: Breakthrough opportunity
• Vietnam advised to fully tap CPTPP to boost exports to Canada
• Vietnamese export goods face increasing trade defence measures in CPTPP markets
• Seminar discusses trade defence risk mitigation for exports to CPTPP
• US loses case over access to Canadian dairy market